In addition, because increased IGF1R expression levels were identified in the nCounter PanCancer Pathway Panel for Gene Expression, in both HAT1-knockdown and HAT1-KO BRAF-mutant melanoma cells (Fig. 4e), we analyzed the mRNA levels as well as protein levels of phospho- and total IGF1R in these samples. The gene discussed is HAT1; the disease is melanoma.